Clinical trial
Comparison of Two Combination Chemotherapy Regimens in Treating Patients With…
NCT00057837 · Eastern Cooperative Oncology Group, Other · Completed
Key facts
| NCT number | NCT00057837 |
|---|---|
| Title | Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Extensive-Stage Small Cell Lung Cancer |
| Official title | A Randomized Phase II Study: Sequencing Topoisomerase Inhibitors for Extensive Stage Small Cell Lung Cancer (SCLC): Topotecan Sequenced With Etoposide/Cisplatin, and Irinotecan/Cisplatin Sequenced With Etoposide |
| Lead sponsor | Eastern Cooperative Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Extensive Stage Small Cell Lung Cancer |
| Intervention type | Biological, Drug |
| Interventions | G-CSF, Cisplatin, Etoposide, Irinotecan, Topotecan |
| Enrollment | 140 |
| Start date | Jul 14, 2004 |
| Primary completion | Jan 1, 2012 |
| Completion | Aug 1, 2012 |
| First posted | Apr 9, 2003 |
| Last update posted | Jul 5, 2023 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: